Mobile health Network Solutions Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $7.3M-47.6% YoYTTM through 31 Dec 2025
Net Income -$2.6MTTM through 31 Dec 2025
Free Cash Flow -$4.4MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 16.7% |
| EBITDA Margin | -32.2% |
| Operating Margin | -46.4% |
| Net Margin | -35.3% |
Returns
-133.2%ROE
-76.0%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio1.05x
Net Debt-$1Mnet cash position
Cash & Equivalents$3.5M
Quality Metrics
Altman Z-Score-2.99
Piotroski F-Score3 / 9
FCF Margin-60.4%
Multi-Year Trend
RevenueFY2025: $7.6M
Diluted EPS-$2.41TTMFY2025: $-3.82
Dividend
No dividend
Capital Allocation
Capex Intensity0.9%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Telemedicine and Other Services | $6.8M | -47.1% | View detailsThe company is scaling its proprietary AI-driven virtual-care platform across high-growth emerging markets, transitioning to an asset-light model to drive long-term profitability. |
| Sale of Medicine and Medical Devices | $846.5K | -23.8% | View detailsFocusing on online e-commerce pharma store and wholesale distribution of pharmaceutical products to clinics through MaNaPharma platform. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.